| [1] |
Vogrig A, Joubert B, André-Obadia N, et al. Seizure specificities in patients with antibody-mediated autoimmune encephalitis[J]. Epilepsia, 2019, 60(8): 1508-1525.
|
| [2] |
Ren Y, Chen X, He Q, et al. Co-occurrence of anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: a clinical phenomenon to be taken seriously[J]. Front Neurol, 2019, 10: 1271.
|
| [3] |
de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH, et al. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis[J]. Neurology, 2019, 92(19): e2185-e2196.
|
| [4] |
Pavan B, Ameer A, Preetam J, et al. A case report: anti-NMDA receptor encephalitis[J]. J Community Hosp Intern Med Perspect, 2018, 8(3): 158-160.
|
| [5] |
Wiseman AC. Immunosuppressive medications[J]. CJASN, 2016, 11(2): 332-343.
|
| [6] |
Gelfand EW. Intravenous immune globulin in autoimmune and inflammatory diseases[J]. N Engl J Med, 2012, 367(21): 2015-2025.
|
| [7] |
中华医学会神经病学分会.中国自身免疫性脑炎诊治专家共识[J].中华神经科杂志, 2017, 50(2): 91-98.
|
| [8] |
Zhang Y, Liu G, Jiang MD, et al. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China[J]. Clin Neurophysiol, 2017, 128(7): 1227-1233.
|
| [9] |
Tanguturi YC, Cundiff AW, Fuchs C. Anti-N-methyl d-aspartate receptor encephalitis and electroconvulsive therapy: literature review and future directions[J]. Child Adolesc Psychiatr Clin N Am, 2019, 28(1): 79-89.
|
| [10] |
Armangue T, Spatola M, Vlagea A, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis[J]. Lancet Neurol, 2018, 17(9): 760-772.
|
| [11] |
Bost C, Chanson E, Picard G, et al. Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies[J]. J Neurol, 2018, 265(10): 2190-2200.
|
| [12] |
Mitra AD, Afify A. Ovarian teratoma associated anti-N-methyl-D-aspartate receptor encephalitis: a difficult diagnosis with a favorable prognosis[J]. Autops Case Rep, 2018, 8(2): e2018019.
|
| [13] |
Dale RC, Nosadini M. Infection-triggered autoimmunity: the case of herpes simplex virus type 1 and anti-NMDAR antibodies[J]. Neurol Neuroimmunol Neuroinflamm, 2018, 5(4): e471.
|
| [14] |
Sharma R, Al-Saleem FH, Puligedda RD, et al. Membrane-bound and soluble forms of an NMDA receptor extracellular domain retain epitopes targeted in auto-immune encephalitis[J]. BMC Biotechnol, 2018, 18(1): 41.
|
| [15] |
Dalmau J, Armangué T, Planagumà J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models[J]. Lancet Neurol, 2019, 18(11): 1045-1057.
|
| [16] |
Royl G, Fokou TJ, Chunder R, et al. Antibodies against neural antigens in patients with acute stroke: joint results of three independent cohort studies[J]. J Neurol, 2019, 266(11): 2772-2779.
|
| [17] |
Iacobucci GJ, Popescu GK. Spatial coupling tunes NMDA receptor responses via Ca2+ diffusion[J]. J Neurosci, 2019, 39(45): 8831-8844.
|
| [18] |
Broadley J, Seneviratne U, Beech P, et al. Prognosticating autoimmune encephalitis: a systematic review[J]. J Autoimmun, 2019, 96: 24-34.
|
| [19] |
Palakkuzhiyil N, Uvais NA, Moideen S, et al. Anti-NMDA-receptor encephalitis presenting with catatonia in a middle aged male[J]. Asian J Psychiatr, 2018, 35: 26-27.
|
| [20] |
贾琳琳.免疫球蛋白联合注射用甲泼尼龙琥珀酸钠冲击治疗自身免疫性脑炎患者的临床效果[J].中国药物经济学, 2021, 16(4): 101-103, 107.
|